$WDAY

KeyBanc Downgrades Workday to Sector Weight From Overweight

KeyBanc downgraded Workday from Overweight to Sector Weight. The company's stock is currently trading at $196.63, up 4.16% in pre-market. The downgrade is based on valuation, EPS revisions, and visibility metrics.

Original reporting
Published Oct 16, 2026, 11:32 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 11:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$WDAY
Bearish
medium confidence
Mentioned
$WDAY
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$WDAYBearishMed
01

Why it matters

The downgrade reflects concerns on valuation and earnings revisions, likely prompting short‑term selling.

02

Market read

Analyst downgrade may trigger immediate price pressure, especially in pre‑market trading.

03

What to watch

Potential upside from upcoming subscription renewals and macro‑economic tailwinds.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

KeyBanc issued a composite rating downgrade for Workday, moving it from overweight to sector weight.

Company-level read

Ticker impact

$WDAYBearishMedium confidence
Context

KeyBanc downgraded Workday to sector weight from overweight, indicating a negative outlook.

Expected impact

likely pressure as investors price in the downgrade

Evidence & confidence

Analyst downgrades typically trigger short-term sell pressure, especially when issued pre‑market.

Market effects

May weigh on the broader enterprise‑software sector as peers could be re‑rated.

U.S. tech‑focused investors may adjust exposure to cloud‑software stocks.

Limited to markets tracking U.S. software equities.

Counterpoint

If Workday's recent product wins offset valuation concerns, the downgrade could be premature.

Key entities

  • Workday

    Enterprise‑software provider (ticker WDAY).

  • KeyBanc

    Research firm providing the downgrade.

Related articles

$WDAYMed

Workday goes headless; CIOs must lay the groundwork

Workday reported a 13% revenue increase but has been reducing its workforce. CEO Aneel Bhusri attributed the cuts to improving business agility. The company showcased headless capabilities and AI agents at its annual conference, aiming to pivot to AI-driven solutions. Workday also announced the acquisition of C1.ai, an agentic identity platform. The company emphasized the importance of high-quality data and CIO involvement in implementing these technologies.

$BMBLHighAI 9/10

Deal Dispatch: Ithaca Holdings Buys Bumble for $1.3B, The Knot Acquires Zola, Character.ai Bankruptcy

Bumble (BMBL) agreed to a $1.3B all-cash acquisition by Ithaca Holdings, becoming privately held. IonQ will acquire Elisity in an all-stock deal up to $1.3B. Agilent (A) to buy Proscia for $240M. Workday (WDAY) acquiring C1.ai. Aurora Cannabis exploring alternatives to Curaleaf's bid. Character.ai filed for bankruptcy, Disney to pay $20M for IP. Getty Images plans Chapter 11, going private with Koch backing.

$WDAYMed

WDAY Downgraded by Keybanc -- Rating Set to Sector Perform

Keybanc downgraded Workday (WDAY) to 'Sector Perform' from 'Overweight', citing cautious near-term outlook. GuruFocus values WDAY at $326.24, 39.7% above its current price of $196.63, with a GF Score of 84/100. Insiders sold $188.8M in shares over three months. Analysts have mixed views, with some raising price targets while others remain cautious.

$WDAYMed

KeyBanc Downgrades Workday (WDAY) Amid AI Growth Concerns

KeyBanc downgraded Workday (WDAY) from Overweight to Sector Weight due to concerns over near-term headwinds in AI-driven product expansion. The company's stock price fell 1% in premarket trading. Workday's GF Value™ suggests it is significantly undervalued at $196.63, with a GF Score™ of 84 indicating strong financial health and growth potential.